Financial Ratios Merchavia Holdings and Investments Ltd
Equities
MRHL
IL0002570146
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175.30 ILa | +0.46% |
|
+3.48% | -18.65% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.25 | 1.93 | -0.36 | -5.42 | -4.51 | |||||
Return on Total Capital | 10.5 | 1.97 | -0.37 | -5.71 | -4.88 | |||||
Return On Equity % | 13.76 | -7.78 | -43.98 | -26.67 | -52.4 | |||||
Return on Common Equity | 13.76 | -7.78 | -43.98 | -26.67 | -52.4 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 100 | 100 | 100 | 100 | 100 | |||||
SG&A Margin | 32.08 | 65.3 | 129.11 | 2.38K | 4.35K | |||||
EBITDA Margin % | 67.44 | 35.3 | -11.31 | -2K | -3.49K | |||||
EBITA Margin % | 67.37 | 35.11 | -11.96 | -2.01K | -3.5K | |||||
EBIT Margin % | 67.37 | 35.11 | -11.96 | -2.01K | -3.5K | |||||
Income From Continuing Operations Margin % | 55.16 | -86.69 | -878.3 | -5.86K | -23.09K | |||||
Net Income Margin % | 55.16 | -86.69 | -878.3 | -5.86K | -23.09K | |||||
Net Avail. For Common Margin % | 55.16 | -86.69 | -878.3 | -5.86K | -23.09K | |||||
Normalized Net Income Margin | 41.95 | 22.14 | -6.93 | -466.39 | -2.15K | |||||
Levered Free Cash Flow Margin | 54.45 | 40.14 | 29.48 | -292.33 | -2.12K | |||||
Unlevered Free Cash Flow Margin | 54.45 | 40.14 | 29.48 | -292.33 | -2.1K | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.24 | 0.09 | 0.05 | 0 | 0 | |||||
Fixed Assets Turnover | 663.06 | 332.88 | 127.45 | 9.92 | 9.78 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 9.59 | 5.45 | 2 | 1.06 | 0.3 | |||||
Quick Ratio | 9.58 | 5.44 | 1.99 | 1.04 | 0.27 | |||||
Operating Cash Flow to Current Liabilities | -3.19 | -2.45 | -1.28 | -0.98 | -0.59 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | - | - | - | - | 4.88 | |||||
Total Debt / Total Capital | - | - | - | - | 4.66 | |||||
Total Liabilities / Total Assets | 1.77 | 1.84 | 4.07 | 6 | 13.77 | |||||
EBIT / Interest Expense | - | - | - | - | -128.5 | |||||
EBITDA / Interest Expense | - | - | - | - | -127.92 | |||||
(EBITDA - Capex) / Interest Expense | - | - | - | - | -127.92 | |||||
Total Debt / EBITDA | - | - | - | - | -0.49 | |||||
Net Debt / EBITDA | -1.04 | -2.89 | 10.51 | 0.58 | -0.26 | |||||
Total Debt / (EBITDA - Capex) | - | - | - | - | -0.49 | |||||
Net Debt / (EBITDA - Capex) | -1.04 | -2.91 | 9.8 | 0.58 | -0.26 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 42.86 | -60.78 | -55.59 | -93.56 | -63.03 | |||||
Gross Profit, 1 Yr. Growth % | 42.86 | -60.78 | -55.59 | -93.56 | -63.03 | |||||
EBITDA, 1 Yr. Growth % | 60.21 | -79.47 | -114.23 | 1.04K | -35.48 | |||||
EBITA, 1 Yr. Growth % | 60.25 | -79.56 | -115.13 | 980.09 | -35.4 | |||||
EBIT, 1 Yr. Growth % | 60.25 | -79.56 | -115.13 | 980.09 | -35.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 95.85 | -161.64 | 349.99 | -57.04 | 45.7 | |||||
Net Income, 1 Yr. Growth % | 95.85 | -161.64 | 349.99 | -57.04 | 45.7 | |||||
Normalized Net Income, 1 Yr. Growth % | 60.71 | -79.3 | -113.91 | 333.17 | 70.5 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 75 | -156.52 | 360.89 | -57.13 | 23.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -40 | 8.33 | 23.08 | -50 | -87.5 | |||||
Total Assets, 1 Yr. Growth % | 26.82 | -6.09 | -34.16 | -17.37 | -28.36 | |||||
Tangible Book Value, 1 Yr. Growth % | 28.63 | -6.16 | -35.66 | -19.03 | -34.28 | |||||
Common Equity, 1 Yr. Growth % | 28.63 | -6.16 | -35.66 | -19.03 | -34.28 | |||||
Cash From Operations, 1 Yr. Growth % | 17.81 | -20.99 | -23.75 | -7.01 | -0.27 | |||||
Capital Expenditures, 1 Yr. Growth % | - | - | 66.67 | - | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -3.98 | -71.09 | -67.38 | -163.84 | 167.98 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -3.98 | -71.09 | -67.38 | -163.84 | 165.83 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 20.52 | -25.14 | -58.26 | -83.09 | -84.57 | |||||
Gross Profit, 2 Yr. CAGR % | 20.52 | -25.14 | -58.26 | -83.09 | -84.57 | |||||
EBITDA, 2 Yr. CAGR % | 21.39 | -42.65 | -82.91 | 27.26 | 171.01 | |||||
EBITA, 2 Yr. CAGR % | 21.37 | -42.77 | -82.42 | 27.82 | 164.15 | |||||
EBIT, 2 Yr. CAGR % | 21.37 | -42.77 | -82.42 | 27.82 | 164.15 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 13.37 | 9.87 | 66.54 | 39.04 | -20.88 | |||||
Net Income, 2 Yr. CAGR % | 13.37 | 9.87 | 66.54 | 39.04 | -20.88 | |||||
Normalized Net Income, 2 Yr. CAGR % | 25.06 | -42.32 | -83.03 | -22.38 | 171.76 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 2.27 | 0.31 | 61.4 | 40.3 | -27.34 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 100 | -19.38 | 15.47 | -21.55 | -75 | |||||
Total Assets, 2 Yr. CAGR % | 25.51 | 9.13 | -21.37 | -26.24 | -23.06 | |||||
Tangible Book Value, 2 Yr. CAGR % | 26.26 | 9.87 | -22.3 | -27.82 | -27.05 | |||||
Common Equity, 2 Yr. CAGR % | 26.26 | 9.87 | -22.3 | -27.82 | -27.05 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.06 | -3.52 | -22.38 | -15.79 | -3.7 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | -37.45 | - | - | - | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 30.87 | -47.31 | -69.29 | -54.36 | 30.8 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 30.34 | -47.31 | -69.29 | -54.36 | 30.28 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 49.19 | -17.1 | -37.1 | -77.62 | -78.05 | |||||
Gross Profit, 3 Yr. CAGR % | 49.19 | -17.1 | -37.1 | -77.62 | -78.05 | |||||
EBITDA, 3 Yr. CAGR % | 78.22 | -32.87 | -63.96 | -30.72 | 1.48 | |||||
EBITA, 3 Yr. CAGR % | 78.53 | -32.97 | -63.27 | -30.62 | 1.81 | |||||
EBIT, 3 Yr. CAGR % | 78.53 | -32.97 | -63.27 | -30.62 | 1.81 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 88.34 | -7.47 | 75.79 | 6.02 | 41.23 | |||||
Net Income, 3 Yr. CAGR % | 88.34 | -7.47 | 75.79 | 6.02 | 41.23 | |||||
Normalized Net Income, 3 Yr. CAGR % | 101.07 | -31.34 | -64.1 | -50.04 | 0.9 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 70.98 | -14.62 | 66.76 | 3.62 | 34.33 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 19.68 | 63.03 | -7.17 | -12.64 | -57.47 | |||||
Total Assets, 3 Yr. CAGR % | 26.19 | 13.94 | -7.79 | -20.06 | -26.95 | |||||
Tangible Book Value, 3 Yr. CAGR % | 26.74 | 14.37 | -8.08 | -21.22 | -30.04 | |||||
Common Equity, 3 Yr. CAGR % | 26.74 | 14.37 | -8.08 | -21.22 | -30.04 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.44 | -4.46 | -10.8 | -17.56 | -10.91 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | - | -13.28 | - | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 34.29 | -20.89 | -55.09 | -60.8 | -17.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 34.28 | -21.1 | -55.09 | -60.8 | -17.88 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 52.58 | -3.94 | -10.37 | -56.11 | -64.15 | |||||
Gross Profit, 5 Yr. CAGR % | 52.58 | -3.94 | -10.37 | -56.11 | -64.15 | |||||
EBITDA, 5 Yr. CAGR % | 64.61 | -9.44 | -30.23 | -13.3 | -19.23 | |||||
EBITA, 5 Yr. CAGR % | 64.97 | -9.49 | -29.36 | -13.23 | -19.14 | |||||
EBIT, 5 Yr. CAGR % | 64.97 | -9.49 | -29.36 | -13.23 | -19.14 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.95 | 48.53 | 79.3 | 8.9 | 27.73 | |||||
Net Income, 5 Yr. CAGR % | 10.95 | 48.53 | 79.3 | 8.9 | 27.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | 18.13 | 10.32 | -25.21 | -27.89 | -19.33 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0 | 37.22 | 68.82 | 4.14 | 19.52 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0 | 1.61 | 17.98 | 21.67 | -45.07 | |||||
Total Assets, 5 Yr. CAGR % | 14.17 | 17.61 | 4.44 | -4.25 | -14.23 | |||||
Tangible Book Value, 5 Yr. CAGR % | 22.2 | 18.38 | 4.21 | -4.86 | -16.2 | |||||
Common Equity, 5 Yr. CAGR % | 22.2 | 18.38 | 4.21 | -4.86 | -16.2 | |||||
Cash From Operations, 5 Yr. CAGR % | 8.86 | -5.23 | -1.51 | -9.17 | -8.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | 5.15 | 37.97 | - | - | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -1.28 | -15.99 | -25.57 | -36.51 | -31.13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -0.47 | -16.37 | -25.57 | -36.62 | -31.24 |
Select your edition
All financial news and data tailored to specific country editions
















